Terms: = Skin cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
530 results:
1. Head and Neck Mucosal Melanoma: Where Are We Now?
Hanba C; Hanna E
Curr Oncol Rep; 2024 Apr; 26(4):421-425. PubMed ID: 38512416
[TBL] [Abstract] [Full Text] [Related]
2. Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
Padonou F; Vanhulst T; Langouo-Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):63-68. PubMed ID: 38441065
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes Following Excision of Toe Glomus Tumors.
Joyson D R K; Sasi P K; Prabhu AJ; Ponmar M; Pallapati SCR
Foot Ankle Int; 2024 Mar; 45(3):243-251. PubMed ID: 38339796
[TBL] [Abstract] [Full Text] [Related]
4. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract] [Full Text] [Related]
5. Head and neck nonmelanoma skin cancers: surgical management and debated issues.
Rampinelli V; Pinacoli A; Piazza C
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):62-70. PubMed ID: 38193646
[TBL] [Abstract] [Full Text] [Related]
6. Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
Benhima N; Belbaraka R; Langouo Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):69-73. PubMed ID: 38193381
[TBL] [Abstract] [Full Text] [Related]
7. Phytochemically analysed extract of Ageratina adenophora (Sprengel) R.M.King & H. Rob. initiates caspase 3-dependant apoptosis in colorectal cancer cell: A synergistic approach with chemotherapeutic drugs.
Chanu KD; Thoithoisana S; Kar A; Mukherjee PK; Radhakrishnanand P; Parmar K; Sharma N
J Ethnopharmacol; 2024 Mar; 322():117591. PubMed ID: 38104872
[TBL] [Abstract] [Full Text] [Related]
8. Scarless Excision of Second Branchial Cleft Cyst via Retroauricular Hairline Incision.
Roh JL
Aesthetic Plast Surg; 2024 Apr; 48(7):1264-1270. PubMed ID: 38097689
[TBL] [Abstract] [Full Text] [Related]
9. Effectiveness and tolerance of electrochemotherapy as palliative therapy for patients with head and neck cancer and malignant melanoma and its relation to early skin reaction.
Caballero-Borrego M; Coll S; Navarrete P
Braz J Otorhinolaryngol; 2024; 90(1):101365. PubMed ID: 38006727
[TBL] [Abstract] [Full Text] [Related]
10. Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting?
Alberti A; Gurizzan C; Baggi A; Bossi P
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):89-95. PubMed ID: 37997885
[TBL] [Abstract] [Full Text] [Related]
11. Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related Schwannomatosis.
Shrivastava M; Emmanouil B; Mathew R; Halliday D; Parry A; Halliday J; Mackeith S
Laryngoscope; 2024 May; 134(5):2364-2371. PubMed ID: 37983868
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathology.
Wang X; Yu H; Gao R; Liu M; Xie W
Eur J Med Res; 2023 Nov; 28(1):532. PubMed ID: 37981715
[TBL] [Abstract] [Full Text] [Related]
13. Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center.
Holmquist A; Wendt M; Papatziamos G; Svensson J; Wester T; Burgos CM; Gahm C
J Pediatr Surg; 2024 Apr; 59(4):678-683. PubMed ID: 37978000
[TBL] [Abstract] [Full Text] [Related]
14. Sono-activated materials for enhancing focused ultrasound ablation: Design and application in biomedicine.
Liao M; Du J; Chen L; Huang J; Yang R; Bao W; Zeng K; Wang W; Aphan BC; Wu Z; Ma L; Lu Q
Acta Biomater; 2024 Jan; 173():36-50. PubMed ID: 37939816
[TBL] [Abstract] [Full Text] [Related]
15. Elective parotidectomy and neck dissection are not beneficial in cutaneous squamous cell carcinoma of the head.
Horakova Z; Starek I; Salzman R
Braz J Otorhinolaryngol; 2024; 90(1):101352. PubMed ID: 37922624
[TBL] [Abstract] [Full Text] [Related]
16. Nivolumab/Relatlimab-rmbw: A Novel Dual Combination Therapy to Treat Adult and Pediatric Patients With Unresectable or Metastatic Melanoma.
Thomas B; Burns M; Pervanas H; Ciurescu D; Dima L
Am J Ther; 2023 Nov-Dec 01; 30(6):e526-e534. PubMed ID: 37921680
[TBL] [Abstract] [Full Text] [Related]
17. What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract] [Full Text] [Related]
18. Schwannomatosis: a Realm Reborn: year one.
Planet M; Kalamarides M; Peyre M
Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial.
Schmidt M; Nitz U; Reimer T; Schmatloch S; Graf H; Just M; Stickeler E; Untch M; Runnebaum I; Belau A; Huober J; Jackisch C; Hofmann M; Krocker J; Nekljudova V; Loibl S;
Eur J Cancer; 2023 Nov; 194():113324. PubMed ID: 37797387
[TBL] [Abstract] [Full Text] [Related]
20. Immune-Related Adverse Events in Patients with Lung cancer.
Sacchi de Camargo Correia G; Pai T; Li S; Connor D; Zhao Y; Lou Y; Manochakian R
Curr Oncol Rep; 2023 Nov; 25(11):1259-1275. PubMed ID: 37782426
[TBL] [Abstract] [Full Text] [Related]
[Next]
